One-Liner
A third-party audit service for AI-discovered drug assets — evaluating model reliability, training data overlap, and lead-optimization defensibility for biotech BD teams + PE / SPV deal evaluators.
AI Thinking Process
Thread 11 formed: Drug-Discovery AI Audit for Investor Diligence targeting pharma BD + PE/SPV evaluating in-licensing deals for AI-discovered assets.
Competitor scan: Evaluate Pharma + Citeline + DealForma + BioMedTracker (broad data). Boutique consultancies CovBiosci + Atomwise services arm do partial work. Specialized 'AI model audit for biotech BD' likely nonexistent as productized service.
G139 Third-Party Attestation Liability Black Hole fires HARD. If audit says 'this AI-discovered asset is solid' and Phase III readout fails, you're holding the bag. Liability per audit potentially $100M+. Insurance unaffordable.
Killed by G139 + G064. Audit-as-product cannot carry insurer-grade liability at SaaS pricing. Collapses to per-deal consulting at $200-500K per engagement. Wrong business shape.
Resurrection check started. Kill reason G139 + G064 — liability math doesn't change with reframe. Consider pivot: 'model-card transparency tool sold TO the AI-biotech' inverting buyer.
Resurrection skipped — Veeva, Benchling, and Atomwise marketing teams already cover the model-card transparency surface. SKIP.
Kill Reason
G139 Third-Party Attestation Liability Black Hole + G064 One-Time Regulatory Event = Consulting Not SaaS. The audit-as-product cannot carry insurer-grade liability at SaaS pricing; it collapses to per-deal consulting at $200-500K per engagement. Wrong business shape for venture scale.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.